Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lunresertib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Debiopharm To Present DDR Inhibition, Dual Payload ADCs, And AI
    Debiopharm To Present DDR Inhibition, Dual Payload ADCs, And AI

    14 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-14/debiopharm-to-unveil-new-pre-clinical-and-clinical-research-advances-in-ddr-inhibition-dual-payload

    PHARMIWEB
    14 Apr 2026
    Share Share
    Repare Therapeutics Licenses Lunresertib to Debiopharm
    Repare Therapeutics Licenses Lunresertib to Debiopharm

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250715559714/en/Repare-Therapeutics-Enters-Exclusive-Worldwide-Licensing-Agreement-with-Debiopharm-for-Lunresertib

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    Repare's Lunresertib-Camonsertib Combo Shows Positive Ph 1 Results
    Repare's Lunresertib-Camonsertib Combo Shows Positive Ph 1 Results

    12 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241212081329/en

    BUSINESSWIRE
    12 Dec 2024
    Share Share
    Repare to Host Webcast on Lunresertib & Camonsertib Data
    Repare to Host Webcast on Lunresertib & Camonsertib Data

    10 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210360746/en

    BUSINESSWIRE
    10 Dec 2024
    Share Share
    Repare Therapeutics Updates Safety Results from MYTHIC Trial
    Repare Therapeutics Updates Safety Results from MYTHIC Trial

    23 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241023356708/en

    BUSINESSWIRE
    23 Oct 2024
    Share Share
    Repare Therapeutics Provides Business and Reports 2nd Quarter 2024
    Repare Therapeutics Provides Business and Reports 2nd Quarter 2024

    06 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240806289967/en

    BUSINESSWIRE
    06 Aug 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.